A Randomised Comparison Of Low Or High Dose Ifn-Alpha In Newly Diagnosed Cml Patients Shows No Difference In Major Cytogenetic Response Rate Or Survival Between The Two Groups - Results Of Mrc Cml V & Hovon 20 Trials.
BLOOD（2001）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要